phosphatase inhibitors (AGY Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namephosphatase inhibitors (AGY Therapeutics)

Drug Alias NamePTP-MEG inhibitors (AGY Therapeutics)STEP inhibitors (AGY Therapeutics)anti-AGY-112 therapeutics (AGY Therapeutics)NMDA-based cognition enhancers (AGY Therapeutics)anti-AGY-111 therapeutics (AGY Therapeutics) +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor agonistsProtein tyrosine phosphatase modulators

TargetsGlutamate [NMDA] receptorProtein tyrosine phosphatase

Therapy Area/IndicationsCognition DisordersAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAgy Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAgy Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsCognition DisordersAlzheimer Disease

Other Information

ATC CodeN/A